Publications by authors named "Andrew H Rodgers"

Claim this Profile
P
Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma.
Philip Friedlander, Lee Roy Morgan, Edmund N Benes, Andrew H Rodgers, Branko Jursic

Anticancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents.
Lee Roy Morgan, Robert F Struck, William R Waud, Blaise LeBlanc, Andrew H Rodgers

Cancer Chemother Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4,4'-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancers.
David Eilender, Patricia LoRusso, Leonard Thomas, Catherine McCormick, Andrew H Rodgers

Cancer Chemother Pharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide.
N Germann, S Urien, Andrew H Rodgers, Marion Ratterree, Robert F Struck

Cancer Chemother Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis